| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | ENR | United States | $17.45 | $2,952,700,000.00 | Buy | 7 | 2015 |
#2 | VRRM | United States | $15.73 | $132,969,000.00 | Buy | 5 | 2016 |
#3 | XHR | United States | $14.80 | $1,078,500,000.00 | Buy | 6 | 2014 |
#4 | ORN | United States | $10.85 | $852,260,000.00 | Strong Buy | 4 | 2007 |
#5 | LEVI | United States | $18.31 | $6,282,000,000.00 | Strong Buy | 13 | 2019 |
#6 | AMRX | United States | $12.71 | $0.00 | Strong Buy | 4 | 2018 |
#7 | LC | United States | $14.59 | $314,702,000.00 | Buy | 6 | 2008 |
#8 | CYRX | United States | $8.01 | $176,177,000.00 | Strong Buy | 9 | 2008 |
#9 | BXMT | United States | $18.94 | $0.00 | Buy | 5 | 1998 |
#10 | KROS | United States | $11.27 | $243,864,000.00 | Buy | 8 | 2020 |
#11 | HLMN | United States | $8.28 | $1,552,224,000.00 | Strong Buy | 5 | 2020 |
#12 | RUN | United States | $12.64 | $858,578,000.00 | Buy | 19 | 2015 |
#13 | APLS | United States | $19.37 | $1,003,782,000.00 | Buy | 20 | 2015 |
#14 | NMRK | United States | $14.02 | $3,294,024,000.00 | Buy | 6 | 2017 |
#15 | XERS | United States | $5.73 | $49,590,000.00 | Strong Buy | 7 | 2021 |
#16 | ALHC | United States | $18.01 | $3,948,719,000.00 | Buy | 10 | 2021 |
#17 | CRNC | United States | $7.01 | $251,781,000.00 | Buy | 4 | 2019 |
#18 | AVAH | United States | $7.02 | $2,024,506,000.00 | Buy | 9 | 2021 |
#19 | MBLY | Israel | $7.85 | $1,894,000,000.00 | Buy | 19 | 2022 |
#20 | QUBT | United States | $7.62 | $682,000.00 | Strong Buy | 5 | 2019 |
#21 | PTON | United States | $3.87 | $0.00 | Buy | 13 | 2019 |
#22 | LXEO | United States | $6.85 | $654,000.00 | Strong Buy | 10 | 2023 |
#23 | SHC | United States | $13.92 | $1,163,617,000.00 | Buy | 7 | 2020 |
#24 | COMP | United States | $8.64 | $6,961,600,000.00 | Strong Buy | 10 | 2021 |
#25 | ADPT | United States | $14.23 | $276,976,000.00 | Strong Buy | 9 | 2019 |
#26 | ARRY | United States | $7.01 | $1,284,141,000.00 | Buy | 19 | 2020 |
#27 | TSHA | United States | $4.52 | $8,333,000.00 | Strong Buy | 9 | 2020 |
#28 | DRVN | United States | $10.54 | $2,339,588,000.00 | Buy | 8 | 2020 |
#29 | PHR | United States | $11.34 | $419,813,000.00 | Strong Buy | 17 | 2019 |
#30 | AOMR | United States | $8.44 | $0.00 | Strong Buy | 4 | 2019 |
#31 | MXL | United States | $16.90 | $478,596,000.00 | Buy | 5 | 2009 |
#32 | REAL | United States | $10.05 | $692,845,000.00 | Buy | 8 | 2019 |
#33 | SHLS | United States | $6.27 | $475,331,000.00 | Buy | 14 | 2020 |
#34 | PHAT | United States | $11.15 | $175,110,000.00 | Strong Buy | 6 | 2019 |
#35 | ENVX | United States | $5.01 | $31,821,000.00 | Buy | 8 | 2020 |
#36 | TARA | United States | $5.60 | $2,948,000.00 | Strong Buy | 7 | 2014 |
#37 | PSNL | United States | $7.95 | $69,648,000.00 | Strong Buy | 6 | 2019 |
#38 | SBH | United States | $14.93 | $3,701,424,000.00 | Buy | 6 | 2006 |
#39 | AIRG | United States | $3.99 | $51,779,000.00 | Strong Buy | 4 | 2016 |
#40 | ONDS | United States | $9.86 | $7,192,694.00 | Strong Buy | 5 | 2015 |
#41 | ADT | United States | $6.57 | $5,128,607,000.00 | Buy | 4 | 2017 |
#42 | OFIX | United States | $12.27 | $822,312,000.00 | Buy | 5 | 1998 |
#43 | SGHT | United States | $3.70 | $77,363,000.00 | Buy | 7 | 2021 |
#44 | AEYE | United States | $5.88 | $35,201,000.00 | Strong Buy | 4 | 2011 |
#45 | ALT | United States | $3.80 | $41,000.00 | Strong Buy | 6 | 2005 |
#46 | FNB | United States | $16.22 | $0.00 | Strong Buy | 5 | 2001 |
#47 | VITL | United States | $17.62 | $759,444,000.00 | Strong Buy | 9 | 2020 |
#48 | GTX | Switzerland | $18.10 | $3,584,000,000.00 | Strong Buy | 4 | 2021 |
#49 | SANA | United States | $3.15 | $0.00 | Strong Buy | 6 | 2021 |
#50 | MDXG | United States | $4.56 | $418,630,000.00 | Strong Buy | 5 | 2007 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (March 11, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.